MicroRNA-34a: A Novel Tumor Suppressor in p53-mutant Glioma Cell Line U251

Archives of Medical Research

Volumn 41, Issue 2, 2010, Pages 67-74

  Luan, Shihai ^a   Sun, Linlin ^a   Huang, Fengping ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; MESSENGER RNA; MICRORNA; MICRORNA 34A; MUTANT PROTEIN; PROTEIN P53; SIRTUIN 1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; WILD TYPE;

BASE SEQUENCE; BRAIN; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GLIOMA; HUMANS; MICRORNAS; SIRTUIN 1; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77952778499     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2010.02.007     Document Type: Article

References (32)

1. Surawicz T.S., Davis F., Freels S., et al. Brain tumor survival: results from the National Cancer Center Data Base. J Neurooncol 1998, 40:151-160.
2. Lowe S.W., Cepero E., Evan G. Intrinsic tumour suppression. Nature 2004, 432:307-315.
3. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature 2000, 408:307-310.
4. Hermeking H. p53 enters the microRNA world. Cancer Cell 2007, 12:414-418.
5. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of posttranscriptional regulation by microRNAs: are the answers in sight?. Nat Rev Genet 2008, 9:102-114.
6. Hatfield S., Ruohola-Baker H. microRNA and stem cell function. Cell Tissue Res 2008, 331:57-66.
7. Carleton M., Cleary M.A., Linsley P.S. MicroRNAs and cell cycle regulation. Cell Cycle 2007, 6:2127-2132.
8. Cho W.C. OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 2007, 6:60.
9. He L., He X., Lim L.P., et al. A microRNA component of the p53 tumour suppressor network. Nature 2007, 447:1130-1134.
10. He L., He X.Y., Scott W., et al. microRNAs join the p53 network-another piece in the tumour suppression puzzle. Nat Rev 2007, 7:819-822.
11. Welch C., Chen Y., Stallings R.L. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 2007, 26:5017-5022.
12. Sun F., Fu H., Liu Q., et al. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett 2008, 582:1564-1568.
13. Fujita Y., Kojima K., Hamada N., et al. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Biochem Biophys Res Commun 2008, 377:114-119.
14. Ji Q., Hao X.B., Meng Y., et al. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 2008, 8:266-302.
15. Yamakuchi M., Ferlito M., Lowenstein C.J., et al. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA 2008, 36:13421-13426.
16. Li N., Fu H., Tie Y., et al. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett 2009, 275:44-53.
17. Yan D., Zhou X., Chen X., et al. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. Invest Ophthalmol Vis Sci 2009, 50:1559-1565.
18. Saunders L.R., Verdin E. Sirtuins: critical regulators at the crossroads between cancer and aging. Oncogene 2007, 26:5489-5504.
19. Kuzmichev A., Margueron R., Vaquero A., et al. Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proc Natl Acad Sci USA 2005, 102:1859-1864.
20. Huffman D.M., Grizzle W.E., Bamman M.M., et al. SIRT1 is significantly elevated in mouse and human prostate cancer. Cancer Res 2007, 67:6612-6618.
21. Hida Y., Kubo Y., Murao K., et al. Strong expression of a longevity-related protein, SIRT1, in Bowen's disease. Arch Dermatol Res 2007, 299:103-106.
22. Yeung F., Hoberg J.E., Ramsey C.S., et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004, 23:2369-2380.
23. Cheng H.L., Mostoslavsky R., Saito S., et al. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci USA 2003, 100:10794-10799.
24. Khokon K.D., Zhong Y., Liu Y.T., et al. Association of microRNA-34a overexpression with proliferation is cell type-dependent. Cancer Sci 2007, 98:1845-1852.
25. Raver-Shapira N., Marciano E., Meiri E., et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007, 26:731-743.
26. Dijkstra1 M.K., van Lom K., Tielemans D., et al. 17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation. Leukemia 2009, 23:625-627.
27. Chang T.C., Wentzel E.A., Kent O.A., et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007, 26:745-752.
28. Wei J.S., Song Y.K., Durinck S., et al. The MYCN oncogene is a direct target of miR-34a. Oncogene 2008, 27:5204-5213.
29. Lu J., Getz G., Miska E.A., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
30. Ciafre S.A., Galardi S., Mangiola A., et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 2005, 334:1351-1358.
31. Kang C.S., Pu P.Y., Jia Z.F., et al. Preliminary study on the miRNA expression profiles in several glioma cell lines. Chin J Neurosurg 2008, 24:468-470.
32. Shono T., Tofilon P.J., Schaefer T.S., et al. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation. Cancer Res 2002, 62:1069-1076.